Tatton Consulting supported Kensington and Chelsea-based Imperial College spinout developing Parkinson’s assessment technology SERG in its successful application to Biomedical Catalyst 2024 Round 1: Industry-led R&D, which was awarded £402,658 by Innovate UK for the project SERG-MED: Parkinson’s ecosystem, powered by a smart wearable platform to provide remote and timely medication titration support.
About the funded R&D project
SERG has built a sequence of Innovate UK-funded projects around Parkinson’s disease assessment and rehabilitation, from telemedicine assessment through closed-loop rehabilitation and mechanomyography sensing for deep brain stimulation. This project develops the resulting Parkinson’s ecosystem, powered by a smart wearable, consolidating that work into a connected clinical offering.
Award details
- Grant awarded: £402,658
- Competition: Biomedical Catalyst 2024 Round 1: Industry-led R&D
- Competition year: 2024/25
- Project: SERG-MED: Parkinson’s ecosystem, powered by a smart wearable platform to provide remote and timely medication titration support
- Sector: Neurology / medical devices
- UKRI project record: Gateway to Research, project 10144107
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title above are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
